$3.09 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 124 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 54.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | HORIZON PHARMA INCnote 5.000%11/1 | $78,189,000 | -5.2% | 16,014,461 | -49.6% | 2.53% | -14.5% | |
| BLUE | Sell | BLUEBIRD BIO INC | $76,243,000 | -2.3% | 631,309 | -25.8% | 2.47% | -11.9% |
| FLML | Sell | FLAMEL TECHNOLOGIES SAsponsored adr | $73,229,000 | -18.7% | 4,072,809 | -22.5% | 2.37% | -26.7% |
| UAM | Sell | UNIVERSAL AMERN CORP NEW | $55,388,000 | +6.3% | 5,186,148 | -7.6% | 1.79% | -4.2% |
| ELGX | Sell | ENDOLOGIX INC | $40,103,000 | -22.4% | 2,349,351 | -30.5% | 1.30% | -30.0% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $38,448,000 | -35.1% | 4,134,157 | -0.1% | 1.24% | -41.5% |
| INSM | Sell | INSMED INC | $33,873,000 | -2.3% | 1,628,531 | -27.4% | 1.10% | -12.0% |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $27,708,000 | -22.5% | 2,810,164 | -3.8% | 0.90% | -30.2% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $21,810,000 | +17.5% | 574,546 | -12.4% | 0.71% | +5.8% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $18,996,000 | -65.0% | 606,118 | -67.4% | 0.62% | -68.4% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $17,802,000 | -55.7% | 3,048,310 | -40.5% | 0.58% | -60.0% |
| TRUP | Sell | TRUPANION INC | $16,815,000 | -9.4% | 2,101,848 | -21.5% | 0.54% | -18.3% |
| OVAS | Sell | OVASCIENCE INC | $14,139,000 | -49.0% | 407,108 | -35.1% | 0.46% | -54.0% |
| JUNO | Sell | JUNO THERAPEUTICS INC | $11,110,000 | -40.6% | 183,149 | -48.9% | 0.36% | -46.4% |
| TRIV | Sell | TRIVASCULAR TECHNOLOGIES INC | $10,387,000 | -28.1% | 990,202 | -13.8% | 0.34% | -35.3% |
| KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $9,744,000 | -41.8% | 765,450 | -35.3% | 0.32% | -47.5% |
| IMMU | Sell | IMMUNOMEDICS INC | $9,598,000 | -28.7% | 2,505,972 | -10.7% | 0.31% | -35.7% |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $6,964,000 | -46.8% | 298,121 | -38.2% | 0.23% | -51.9% |
| AMPH | Sell | AMPHASTAR PHARMACEUTICALS IN | $6,710,000 | -54.7% | 448,532 | -64.9% | 0.22% | -59.2% |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $6,287,000 | +20.4% | 679,627 | -8.8% | 0.20% | +8.5% |
| LMNS | Sell | LUMENIS LTD | $5,202,000 | -6.8% | 434,566 | -27.3% | 0.17% | -16.4% |
| PRQR | Sell | PROQR THRAPEUTICS N V | $4,582,000 | -44.4% | 209,398 | -44.9% | 0.15% | -50.0% |
| SCYX | Sell | SCYNEXIS INC | $4,090,000 | -18.0% | 492,781 | -1.4% | 0.13% | -26.3% |
| KIN | Sell | KINDRED BIOSCIENCES INC | $1,994,000 | -24.0% | 279,204 | -20.8% | 0.06% | -30.9% |
| MEIP | Sell | MEI PHARMA INC | $1,437,000 | -88.6% | 802,568 | -72.7% | 0.05% | -89.6% |
| PARNF | Sell | PARNELL PHARMACEUT HLDGS LTD | $1,245,000 | -20.1% | 253,592 | -32.5% | 0.04% | -28.6% |
| PTBI | Sell | PLASMATECH BIOPHARMACEUTICAL | $1,099,000 | -14.5% | 349,908 | -6.0% | 0.04% | -21.7% |
| ONTY | Sell | ONCOTHYREON INC | $233,000 | -69.2% | 143,200 | -64.1% | 0.01% | -70.4% |
| MSTX | Exit | MAST THERAPEUTICS INC | $0 | – | -700,000 | -100.0% | -0.01% | – |
| KND | Exit | KINDRED HEALTHCARE INC | $0 | – | -37,611 | -100.0% | -0.02% | – |
| ZTS | Exit | ZOETIS INCcl a | $0 | – | -25,097 | -100.0% | -0.04% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -10,000 | -100.0% | -0.05% | – |
| SLXP | Exit | SALIX PHARMACEUTICALS INC | $0 | – | -11,500 | -100.0% | -0.05% | – |
| EXEL | Exit | EXELIXIS INCcall | $0 | – | -1,000,000 | -100.0% | -0.05% | – |
| FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -99,847 | -100.0% | -0.07% | – |
| ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -1,691,857 | -100.0% | -0.10% | – |
| OCRX | Exit | OCERA THERAPEUTICS INC | $0 | – | -461,119 | -100.0% | -0.11% | – |
| MRGE | Exit | MERGE HEALTHCARE INC | $0 | – | -892,897 | -100.0% | -0.11% | – |
| THOR | Exit | THORATEC CORP | $0 | – | -102,919 | -100.0% | -0.12% | – |
| KBIO | Exit | KALOBIOS PHARMACEUTICALS INC | $0 | – | -2,286,783 | -100.0% | -0.14% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS INC | $0 | – | -284,653 | -100.0% | -0.16% | – |
| PFNX | Exit | PFENEX INC | $0 | – | -625,640 | -100.0% | -0.16% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -464,083 | -100.0% | -0.20% | – |
| Exit | SPECTRANETICS CORPmtnf 2.625% 6/0 | $0 | – | -5,439,000 | -100.0% | -0.25% | – | |
| CNXR | Exit | CONNECTURE INC | $0 | – | -799,750 | -100.0% | -0.26% | – |
| TRNX | Exit | TORNIER N V | $0 | – | -288,971 | -100.0% | -0.26% | – |
| Exit | ACCURAY INCnote 3.500% 2/0 | $0 | – | -5,000,000 | -100.0% | -0.27% | – | |
| KITE | Exit | KITE PHARMA INC | $0 | – | -155,799 | -100.0% | -0.32% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -60,393 | -100.0% | -0.34% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -164,800 | -100.0% | -0.44% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -1,870,943 | -100.0% | -0.51% | – |
| RMD | Exit | RESMED INC | $0 | – | -296,300 | -100.0% | -0.60% | – |
| CBST | Exit | CUBIST PHARMACEUTICALS INC | $0 | – | -210,200 | -100.0% | -0.76% | – |
| Exit | TESARO INCnote 3.000%10/0 | $0 | – | -27,123,000 | -100.0% | -1.22% | – | |
| HUM | Exit | HUMANA INCcall | $0 | – | -280,000 | -100.0% | -1.44% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -1,047,093 | -100.0% | -1.46% | – |
| AGN | Exit | ALLERGAN INCcall | $0 | – | -200,000 | -100.0% | -1.53% | – |
| RNA | Exit | PROSENSA HLDG N V | $0 | – | -3,316,434 | -100.0% | -2.23% | – |
| Exit | AMAG PHARMACEUTICALS INCnote 2.500% 2/1 | $0 | – | -45,020,000 | -100.0% | -2.69% | – | |
| AGN | Exit | ALLERGAN INC | $0 | – | -606,601 | -100.0% | -4.63% | – |
| AUXL | Exit | AUXILIUM PHARMACEUTICALS INC | $0 | – | -6,267,382 | -100.0% | -7.74% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.